Status:
UNKNOWN
Biomarkers for Early Detection of Lung Cancer in Patients With Lung Cancer, Participants at High-Risk for Developing Lung Cancer, or Healthy Volunteers
Lead Sponsor:
South West Wales Cancer Institute
Conditions:
Lung Cancer
Tobacco Use Disorder
Eligibility:
All Genders
Brief Summary
RATIONALE: Collecting and storing samples of sputum and tissue to study in the laboratory may help doctors identify biomarkers related to cancer. PURPOSE: This research study is looking samples of sp...
Detailed Description
OBJECTIVES: * To test and make a preliminary assessment of the sensitivity and specificity of Fourier transform infrared technology (FTIR) for use in the early detection of lung cancer in sputum samp...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Meets 1 of the following criteria:
- Diagnosis of lung cancer
- At high risk for developing lung cancer
- Non-high-risk smoking or non-smoking volunteer (control)
- PATIENT CHARACTERISTICS:
- Not specified
- PRIOR CONCURRENT THERAPY:
- Not specified
Exclusion
Key Trial Info
Start Date :
April 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00899262
Start Date
April 1 2008
Last Update
August 26 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince Philip Hospital
Llanelli, Wales, United Kingdom, SA14 8QF
2
South West Wales Cancer Institute
Swansea, Wales, United Kingdom, SA2 8PP